Congratulations to these exceptional leaders from the Saudi General Directorate for Health Services, Ministry of Defense for completing our Global Transformational Leadership program! Over the course of three weeks, they gained insights and exposure to the latest advancements in safety, quality, service and innovation within our hospital system. We are inspired by their commitment to excellence and are proud to partner with them in advancing global health care. #HealthcareLeadership #GlobalPartnerships #Innovation #LeadershipDevelopment #GlobalTransformationalLeadership
Houston Methodist
医院和医疗保健
Houston,Texas 129,529 位关注者
No. 1 Employer in Texas on the list of “America’s Best Employers by State” by Forbes and Statista
关于我们
Houston Methodist is one of the nation’s leading health systems and academic medical centers. The health system consists of eight hospitals: Houston Methodist Hospital, its flagship academic hospital in the Texas Medical Center, seven community hospitals and one long-term acute care hospital throughout the Greater Houston metropolitan area. Houston Methodist also includes a research institute; a comprehensive residency program; international patient services; freestanding comprehensive care, emergency care and imaging centers; and outpatient facilities. Houston Methodist employs more than 32,000 people. Come lead with us.
- 网站
-
https://www.houstonmethodist.org
Houston Methodist的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 超过 10,001 人
- 总部
- Houston,Texas
- 类型
- 非营利机构
- 领域
- Health Care
地点
Houston Methodist员工
动态
-
Our neuro-ophthalmologist Dr. Andrew Lee discusses spaceflight associated neuro-ocular syndrome (SANS) and the research to help astronauts’ vision during extended flights. Learn more on YouTube: https://spr.ly/6046svfCy
-
What does it take to provide world-class care across 350+ ICU beds? Dr. FAISAL MASUD MD FCCM, FCCP, medical director of our Center for Critical Care, shares how his team makes it happen on Quality Time with Dr. Shlomit Schaal, MD, PhD, MHCM. Listen on Spotify: https://spr.ly/6044spsbK
-
Cardiac electrophysiologist Dr. Miguel Valderrabano, MD, PhD will present on coronary venous ethanol for ablation of persistent atrial fibrillation at #AHA24. https://spr.ly/6042sJcl8
-
Our cardiologist Dr. Kershaw Patel will present a post-hoc analysis of the Look AHEAD trial, which looked at intensive lifestyle intervention, cardiac biomarkers & atherosclerotic cardiovascular disease in type 2 diabetes & overweight or obesity at #AHA24. https://spr.ly/6047sJczJ
-
This episode of Women in Surgery was especially interesting because our Chief Physician Executive Dr. Shlomit Schaal, MD, PhD, MHCM was joined by two special guests. With our Chief of Foregut & Minimally Invasive Surgery Dr. Patrick R Reardon and general surgery resident Dr. Connie Au, MD, they talked about how much general surgery training has changed for women over the years and what women can now expect during residency. Hear the full conversation on YouTube: https://spr.ly/6048sOtoq
-
During a routine physical, Steven worried he may have a hemorrhoid. It was colorectal cancer. He shares his journey to cancer survivorship to help others when facing cancer. Watch Steven's story on YouTube: https://spr.ly/6044Sa4pa
-
Last week, Houston Methodist Global Health Care Services hosted our end of year gathering in Riyadh, participated in Saudi Arabia's Global Health Exhibition - ????? ????? ??????? signing memorandums with Ministry of National Guard Health Affairs (MNGHA) and National Medical Care Company, took part in King Faisal Specialist Hospital and Research Center’s Gastrointestinal Transplant Oncology Symposium, visited our strategic partner Qatar Cancer Society and took part in the first ever Relay for Life Cancer Walk in the Middle East in Doha. It was a great opportunity to expand our collaborative efforts and commitment to leading medicine for our regional patients and partners.
-
+2
-
Professor of Cardiovascular Surgery Dr. Michael Reardon presented late-breaking one-year outcomes of the ACURATE IDE trial, which looked at ACURATE neo2 vs approved TAVR devices in all-risk patients with severe aortic stenosis at #TCT2024. https://spr.ly/6048S6qpn
-
Cardiologist Dr. Stephen Little will be a discussant on the late-breaking clinical trials session in collaboration with the New England Journal of Medicine (NEJM Group). https://spr.ly/6048S6qOi